This stock is up nearly 30-fold since 2000 and is stock in a company that is known by many (and frequented by many who work on Wall Street). Yet despite this, not a single Wall Street analyst covers it, making it one of two incredible “Orphan Stocks” (the second, a medical device company) to consider adopting. CLICK HERE.
